Home » Topics » Disease categories and therapies » Substance use and poisoning

Substance use and poisoning
RSS

Positive phase I/II results for NicVAX

March 4, 2004

Cytos' Immunodrug for nicotine addiction enters phase II trial in smokers

Jan. 20, 2004

ICL-670 in beta-thalassemia and associated transfusional iron overload

Dec. 12, 2003

Preliminary phase III results for Vivitrex show reductions in heavy drinking

Dec. 11, 2003

Potential use of SB-277011-A in preventing relapse to cocaine abuse

Nov. 28, 2003

Promising results for ferumoxytol in anemia and chronic kidney disease

Nov. 27, 2003

Britannia and US WorldMeds sign licensing agreement for lofexidine

Nov. 21, 2003

Novel 5-HT and/or dopamine receptor ligands discovered by Sepracor team

Nov. 19, 2003

Antalarmin reduces volitional ethanol consumption in rats

Nov. 18, 2003

Neramexane shows promise for the treatment of alcohol dependence

Nov. 18, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 25, 2026.
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...